Community Health Care, Inc.

Canal Fulton, Ohio 44614

0 studies enrolling now · 8 studies all time

What they study most

Atrial Fibrillation, Atrial Flutter, Hyperlipidemia, Major Depressive Disorder, Type 2 Diabetes, Type 2 Diabetes Mellitus, Venous Thrombosis

Studies at this site

• An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
• Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes — Completed
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy — Completed